Author

Davey Smith

University of California San Diego

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Adolfo García‐SastreiD· 1 shared Asha Z. GoodmaniD· 1 shared Briana Lynn McGoverniD· 1 shared Daniel J. HadersiD· 1 shared Emilia Mia SordilloiD· 1 shared Gustavo VaseniD· 1 shared Harm van BakeliD· 1 shared Kris M. WhiteiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Adolfo García‐SastreORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MDL-001: an Oral, Direct-Acting Broad-Spectrum Antiviral for Influenza-Like Illness (ILI) and Chronic Hepatitis In Vivo

Virgil L. Woods, Tyler J. Umansky, Sean M. Russell, Asha Z. Goodman, Michael D. Bobardt, Briana Lynn McGovern, Romel Rosales, M. Luis Rodriguez, Harm van Bakel, Emilia Mia Sordillo, Viviana R. Simon, Adolfo García‐Sastre, Kris M. White, Philippe A. Gallay, Davey Smith, Daniel J. Haders

This paper evaluates MDL-001, a broad-spectrum antiviral, showing potent in vitro and in vivo activity against influenza, RSV, SARS-CoV-2, and hepatitis B/C/D viruses, with improved efficacy compared to existing treatments.

Pharmaceuticals · Oct 18, 2026Peer-reviewedPharmacology & Toxicology

Limitations of inferring antiviral efficacy of interfering particles from observational natural histories

Neha Khetan, Gustavo Vasen, Davey Smith, Leor S. Weinberger

The paper critiques the validity of using observational data to infer the antiviral efficacy of therapeutic interfering particles (TIPs) and highlights inconsistencies in reported viral dynamics.

bioRxiv · Mar 12, 2026 · PreprintMicrobiology